The new research will include initiatives geared toward developing infection prevention techniques by using microorganisms present in the human body, or microbiome, to predict and assess the possibility of infections caused by drug-resistant bacteria.
“Understanding the role the microbiome plays in antibiotic-resistant infections is necessary to protect the public’s health,” said CDC Director Tom Frieden, MD. “We think it is key to innovative approaches to combat antibiotic resistance, protect patients and improve antibiotic use.”
The majority of the new research will be conducted through universities across the country.
For a full list of research locations, click here.
More articles on infection control:
Researchers develop new device to test for antibiotic-resistant bacteria
CMS finalizes new rule requiring nursing homes to have antibiotic stewardship programs
Bloodstream infection clusters across 3 states may be associated with central lines
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
